Furthermore, administration of 1-methyl-tryptophan (an IDO inhibitor) in combination with PD-L1 and CTLA-4 inhibitors resulted in 100% glioma mice survival, improved over PD-L1 and CTLA-4 dual inhibitor therapy [111]. The gene discussed is IDO1; the disease is central nervous system cancer.